Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
1
20%
Ph phase_1
2
40%

Phase Distribution

2

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 1Safety & dosage
2(50.0%)
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

5

all time

Status Distribution
Other(5)

Detailed Status

unknown5

Development Timeline

Analytics

Development Status

Total Trials
5
Active
0
Success Rate
N/A
Most Advanced
Phase 2

Trials by Phase

Phase 12 (50.0%)
Phase 21 (25.0%)
N/A1 (25.0%)

Trials by Status

unknown5100%

Recent Activity

0 active trials
Showing 5 of 5
unknownnot_applicable

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

NCT03182296
unknown

Exendin PET/CT for Imaging of Paragangliomas

NCT05418907
unknownphase_2

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

NCT04615910
unknownphase_1

GLP1R-imaging in Hypoglycemia

NCT03182192
unknownphase_1

GLP1-imaging Before and After Bariatric Surgery

NCT03182231

Clinical Trials (5)

Showing 5 of 5 trials
NCT03182296Not Applicable

Visualizing Beta Cells in Patients With a History of Gestational Diabetes

Unknown
NCT05418907

Exendin PET/CT for Imaging of Paragangliomas

Unknown
NCT04615910Phase 2

A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

Unknown
NCT03182192Phase 1

GLP1R-imaging in Hypoglycemia

Unknown
NCT03182231Phase 1

GLP1-imaging Before and After Bariatric Surgery

Unknown

All 5 trials loaded

Drug Details

Intervention Type
RADIATION
Total Trials
5